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The aim of this work is to determine the antibacterial activity of three marketed mouthwashes on suspended and sessile states
of Aggregatibacter actinomycetemcomitans. The efficacy of two commonly used products in clinical practice, containing essential
oils as active ingredients (menthol, thymol, methyl salicylate, and eucalyptol) in association with or without alcohol, has been
evaluated in comparisonwith a chlorhexidine-basedmouthwash.Themicrotiter plate assay, in order to obtain a spectrophotometric
measurement of bacterial responses at growing dilutions of each antiseptic, was used for the study.The analysis revealed that a good
antibacterial activity is reached when the abovementioned mouthwashes were used at concentration over a 1/24 dilution and after
an exposure time of 30 seconds at least. In conclusion, the alcoholic mouthwash appears to have a better biofilm inhibition than its
antiplanktonic activity while the nonalcoholic product demonstrates an opposite effect with a better antiplanktonic behavior.
1. Introduction
Aggregatibacter actinomycetemcomitans (Aa) is a gram-nega-
tive coccobacillus, facultative anaerobe, closely associated
with the aetiology of severe periodontitis, but it is also impli-
cated in different human systemic diseases, such as infective
endocarditis and, rarely, in brain abscesses, osteomyelitis,
or low birth weight [1–4]. In particular, Aa virulence is
strongly linked to the production of the leukotoxin (ltxA),
homologous to repeats-in-toxin (RTX) family. Although not
all Aa strains can determine an AgP, high levels of ltxA
have been always detected in AgP related to Aa infection
[5]. Clones with different leukotoxin-producing abilities have
been identified, and this intraspecies diversity of Aa referred
to specific genotypes named 652, JP2, and, more recently, Y4
[1, 5–7]. Clinically, it is one of themicroorganisms responsible
for both aggressive periodontitis (AgP) and chronic peri-
odontitis (ChP). These affections are chronic inflammations
of the periodontal tissues related to the presence of subgin-
gival bacteria that occur in severe forms in 5–20% of adult
populations, according to what was recently reported by The
World Health Organization [8–10].
It has been recognized that both regular supportive
periodontal therapy and the domiciliary oral hygiene, related
to supragingival plaque control through a host modulation of
periodontal bacteria, are essential for obtaining a good clin-
ical outcome [11]. In this context, the use of a local chemical
antiseptic able to inhibit the plaque biofilm formation could
be fundamental to support the mechanical therapy [11–13].
At the same time, as previously stated, Aa plays an important
role as an etiological agent of systemic diseases when it dis-
seminates in the bloodstream. Oral bacteria could promote a
transient bacteraemia, during all the dental procedures, with
variable severity. This variability could be related to both the
kind of treatment and the level of communication established
between oral cavity and bloodstream [14].
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In this study, three commercially available mouthwashes
as DayCare, Listerine, and Dentosan have been tested. Day-
Care (Curaden Healthcare, Via G. Parini, 19-Saronno VA)
and Listerine (Johnson & Johnson Consumer Healthcare,
Morris Plains, NJ, USA) are both based on the same essential
oils combination (menthol 0,042%, thymol 0,064%, methyl
salicylate 0,06%, and eucalyptol 0,0092%) but differ in terms
of the absence of alcohol (Daycare) or the presence of
alcohol with a concentration of 26,2% (Listerine). They show
both bacteriostatic and bactericidal activities that are related
to cell wall disruption and enzymatic inhibition. Dentosan
(Johnson & Johnson Consumer Healthcare, Morris Plains,
NJ, USA) is a chlorhexidine (CHX-) based mouthrinse, and
it is recognised as the most effective chemical agent, usable
in the oral cavity, for biofilm inhibition. It exists in three
different concentrations (0.20%, 0.12%, and 0.05%) related
to its clinical use. For this analysis, the percentage of CHX
chosen is 0.12%, that is, the concentration commonly used
for biofilm modulation in long-term therapies [12, 15, 16]. Its
antibacterial activity is linked to the capability of binding to
bacterial cell membrane. This determines an increased per-
meability at low concentrationwhile, at high concentration, it
causes a precipitation of bacterial cytoplasmwith bactericidal
effect [15, 16].
The aim of this work is to evaluate these commercial
mouthwashes activity in order to prevent Aa biofilm for-
mation. In particular, their antimicrobial effect has been
tested by calculating the minimum inhibitory concentration
(MIC), the minimum bactericidal concentration (MBC), and
the minimal eradication biofilm concentration (MEBC) [17].
Additionally, the bactericidal effect of tested mouthwashes
will be evaluated in relation to the exposure time. Therefore,
Aa viability will be estimated after 10, 20, 30, 40, 50, and
60 seconds of exposure to each mouthwashes at the MBC
dilution.
The results will allow to estimate the effect on planktonic
growth (PG) and on biofilm development (BD) of essential
oil-based mouthwashes with or without alcohol, and it will
be compared with CHX activity.
2. Materials and Methods
2.1. Bacterial Strain and Growth Condition. This study was
performed using a strain of Aggregatibacter actinomycetem-
comitans DSM 11123 [18] from the Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH (German Collec-
tion ofMicroorganisms and Cell Cultures).The bacteria were
grown in anaerobic difficile agar (Microbiol, UTA, Cagliari,
Italy) at 37∘C for 24 hours with a CO
2
concentration of
5%. After the incubation, the Aa was suspended in vials
containing Schaedler broth to obtain a concentration with a
turbidity equivalent to the No. 3 McFarland standard (about
108 CFU/mL) then diluted to 1/100 (obtaining a 106 CFU/mL)
using a spectrophotometer at 620 nm (DMS100s, Varian, NH,
USA) [19].
2.2. MIC, MBC, and MEBC Evaluation. To analyze antibac-
terial activity, 200𝜇L of each previously described suspended
strain was added to eleven wells of a 96-well plate and incu-
bated for 48 h incubation at 37∘C with a CO
2
concentration
of 5%. Before incubation, each mouthwashe was added to the
bacterial suspension following a scalar concentration pair to
𝐷 = 1/2
𝑛 (where 𝐷 is the dilution factor and 𝑛 is equal
to a number from 1 to 11 following wells sequence). After
incubation, the PG was evaluated with spectrophotometric
method using a microtiter plate reader with a lecture at
620 nm (SLT-Spectra II, SLT Instruments, Germany). In
order to establish when themouthwashes reach the bacterici-
dal concentration, whenever the spectrophotometric analysis
showed an absorbance value equal to 0.000 for PG (equivalent
to the absence of bacterial growth), subcultures in difficult
anaerobic agar were performed to determine the MIC and
MBC. To determine the MEBC, the method of the microtiter
plate biofilm production assay was used [20]. All the analyses
were performed three times in order to be able to do an
analysis of the variance (ANOVA).
2.3. Exposure Time Analysis. Once the MBC was identi-
fied, the time required for each mouthwash to reach the
bactericidal effect was tested. Each product was therefore
placed in 6 tubes containing a bacteria concentration equal
to 106 CFU/mL. Sequentially, a sample was performed from
each tube every 10 seconds, and a subculture in anaerobic
difficile agar was prepared in order to determine the residual
bacterial viability in relation with six different exposure times
(from 10 to 60 seconds).
2.4. Microtiter Plate Biofilm Production Assay. To perform
BD analysis, the method of the microtiter plate biofilm pro-
duction assay was used [20, 21]. After the incubation, the
medium was removed and the microtiter plate wells were
washed three times, with 200𝜇L of PBS (0.1M, pH 7.4) buffer
using a pipette, and allowed to dry for 15min. The microtiter
wells were stained with 200 𝜇L of 0.4% crystal violet for
15min. at room temperature.Theunbound crystal violet stain
was removed, and the wells were washed three times with
200𝜇L of PBS buffer. The wells were air-dried for 15min,
and the crystal violet in each well was solubilized by adding
200𝜇L of 33% acetic acid. At the end of the coloration, the
biofilm was evaluated using the microtiter plate reader (SLT-
Spectra II, SLT Instruments, Germany) at 620 nm.
2.5. Statistical Analysis. To analyze the different effect that
each mouthwash had on BD and PG, a statistical compari-
son has been applied. For this reason, the absorbance val-
ues were replaced with comparing values from 0 to 1 and, in
particular, the value 1 was always correlated to the absorb-
ance value obtained with the dilution equal to 1/211. To
perform the comparison between different mouthwashes
effect, antiplanktonic and antibiofilm activities were analyzed
separately using the raw absorbance values. To compare the
results obtained from different moutwashes and from differ-
ent bacterial state (Planktonic or Biofilm), the absorbance
raw values were converted. To perform this conversion each
value were transformed into a number from 0 to 1 using as
1 the absorbance value related to the dilution equal to 1/211
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Table 1:The table is divided to three parts: in the first part the statistical analysis of total antibacterial effect by using of absolute values related
to PG and PD separately is shown. In the second part there is the statistical analysis of anti-PG and anti-BD activity separately. In the third
part MIC, MBC, and MEBC for each mouthwash are shown.
Sup. Mean Inf. Dv.St PG mean BD mean Dev.St 𝑃 value MBC MIC MBEC
Dentosan 0,340 0,182 0,024 0,356 0,134 0,231 0,069 0,192 1/29 1/29 1/28
Listerine 0,512 0,345 0,178 0,376 0,396 0,297 0,070 0,095 1/23 1/23 1/24
DayCare 0,468 0,291 0,114 0,398 0,186 0,396 0,149 0,032 1/26 1/26 1/24
(i.e., if the 1/211ABS raw value is equal to 1.29 it become 1, so
all the previous raw value (𝑅) related to the same mouthwash
and the same bacterial state will be converted in this way:
𝑥 = 𝑅/1.29). Statistical analysis was performed using the two-
way ANOVA procedure with a dedicated software (Minitab,
version 15.1.1.0 for Windows, Minitab Inc., State College, PA,
USA). Statistical significance was assumed at 𝑃 value inferior
or equal to 0,05.
3. Results
From the statistical analysis, it was possible to highlight
how bacterial viability is always related to the dilution factor
(𝑃 < 0,0005). It is noticed that Dentosan is the most ef-
fective mouthwash against both PG and BD without any
specific activity (𝑃: 0,192). Listerine inhibits the BD at a
minor dilution despite the dilution necessary to have the
antiplanktonic activity, obtaining MEBC at the left of the
MBC/MIC (1/24 against 1/23). However, a statistic relevance
that highlighted a difference between its antiplanktonic and
the antibiofilm effects was not found (𝑃: 0,095) (Table 1).
BD and PG inhibition by DayCare shows a peculiar
behavior, whereasDentosan and Listerine have only one dilu-
tion exponent of difference between MEBC and MBC/MIC
(resp., 1/28 against 1/29 for Dentosan and 1/24 against 1/23
for Listerine) for DayCare two exponents of difference (1/24
against 1/26) with a 𝑃-value statistically relevant could be
noticed (𝑃 value: 0,032) (Table 1).
By the analysis of antiplanktonic and antibiofilm activities
separately, it was possible to determine some differences
between mouthwashes in terms of raw ABS values. In both of
the antibacterial effects, there is a statistical difference related
to the mouthwash examined (𝑃: 0,002 for anti-planktonic
effect and 𝑃: 0,017 for antibiofilm activity). For MBC/MIC
activity, the worst mouthwash is Listerine with an optically
determined bacterial growth, yet with a concentration of
1/24, followed by DayCare at 1/28. The best is Dentosan that
inhibited bacterial growth until a dilution of 1/29 (Table 1). In
the antibiofilm evaluation, Listerine was the first mouthwash
in which it was possible to measure the BD with an MEBC
at a dilution of 1/24. Although the Listerine does not have a
highMEBC, it showed to have a good biofilm inhibition until
the higher dilution tested (1/211) with ABS values minor then
registered for Dentosan. As for the MBEC, the best activity
was again the one of Dentosan (1/28) while the worst effect
was found for DayCare that showed the highest level of ABS
for biofilm, yet with a dilution of 1/27 (Figure 2, Table 1). In
analyzing the raw values of absorbance related to PG and





















Figure 1: Comparison between absolute values of absorbance
related to the PG of Aa when exposed to growing dilution (from 1/2
to 1/2048) of the tested mouthwashes.
BD separately it was possible to highlight a good activity of
DayCare against PG in contrast to the worst activity on BD
inhibition related to other mouthwashes (Table 1, Figures 1
and 2). Allmouthwashes tested presented a good antibacterial
activity when they are used at concentration under a dilution
of 1/24. From the exposure time analysis, Dentosan and
Listerine were found to inhibit bacterial viability after only 10
and 20 seconds, respectively, whileDayCare needs 30 seconds
to obtain a totally bactericidal effect.
4. Discussion
Recently, mouthwashes have obtained a great importance as
therapeutic keystone against oral infections such as caries,
candidiasis, and especially periodontitis.Their activity can be
applied for pathology prevention, as well as for preventing
systemic pathologies linked to transient bacteraemia that is
always generated during dental manipulations [3, 14, 22]. A
good mouthwash should have a good antibacterial activity
against both PG and BD in order to prevent all these
conditions.Thepresent analysis is focused on the study of this
double effect, fundamental to evaluate the real antibacterial
power of each mouthwash [23].
From the results, the huge difference between mouth-
washes activity against Aa in its planktonic and biofilm
4 International Journal of Dentistry






















Figure 2: Comparison between absolute values of absorbance
related to the BD of Aa when exposed to growing dilution (from
1/2 to 1/2048) of the tested mouthwashes.
forms clearly appears. Firstly, alcoholic products behave in
a different way from the other two mouthwashes so that,
while they have the worst effect against PG, they show at
the same time the best antibiofilm activity at high dilution.
In accordance with the literature, essential oils with alcohol
have the best antibiofilm activity [23–25]. On the base of
these results, it seems that an alcoholic mouthwash could be a
good choice in preventing plaque formation after periodontal
therapies.
In contrast, essential oil nonalcoholic mouthwashes show
a better antiplanktonic rather than antibiofilm activity. In this
case, it could be considered a good choice in order to prevent
bacterial systemic dissemination. In particular, they could be
useful for treating specific anatomic areas with a high risk of
bacteraemia.
At the same time, it is reported how transient bacteraemia
could be determined not only during some clinical proce-
dures or in particular conditions but also through subclinical
dental infection or daily dental brushing [14, 26]. Patients
with underlying cardiopathy or with oral condition with high
risk of oral bacteria dissemination need to be supported by
an adequate prophylaxis through local antiseptic products.
Although Aa PG seems to be susceptible to all tested mouth-
washes, it becomes necessary to refer to a mouthwash with
a strong anti-planktonic activity in case of therapies with an
high risk of bacterial dissemination from the oral cavity.
In conclusion, this work acknowledges howboth essential
oil-based mouthwashes, with or without alcohol, have a
good and comparable antibacterial power when they are
used pure on Aa. In accordance with the literature, it was
demonstrated that all of them showed the bactericidal effect
within the maximum exposure time in vivo (60 seconds)
even though the bacterial response fluctuates significantly
after consecutive dilutions of tested antiseptics, as previously
described. However, further studies on the chemical impact
of alcohol as well as the action of the active ingredients
of the referred mouthwashes will be needed to more full
investigation.
These results suggest that it is necessary for clinicians to
understand bothmouthwashesmolecules and the pathogenic
agents involved in order to obtain a therapeutic effect. Further
studies will be needed to confirm these results in vivo and on
others bacterial species.
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